Cite

    Fogarasi, A. et al. (2020). Open‐label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic‐clonic seizures. Epilepsia. pp. 125-137. [Online].